BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 12572089)

  • 1. [Transport to an infected site of azithromycin by phagocyte cells].
    Enogaki K
    Jpn J Antibiot; 2000 Jun; 53 Suppl B():60-71. PubMed ID: 12572089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacokinetics and tissue distribution of azithromycin in humans].
    Shiba K
    Jpn J Antibiot; 2000 Jun; 53 Suppl B():43-59. PubMed ID: 12572088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular uptake and efflux of azithromycin, erythromycin, clarithromycin, telithromycin, and cethromycin.
    Bosnar M; Kelnerić Z; Munić V; Eraković V; Parnham MJ
    Antimicrob Agents Chemother; 2005 Jun; 49(6):2372-7. PubMed ID: 15917536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Azithromycin in the field of dermatology].
    Arata J
    Jpn J Antibiot; 2000 Jun; 53 Suppl B():111-6. PubMed ID: 12572094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [In vitro and in vivo antibacterial activities of azithromycin].
    Miyazaki S; Yamaguchi K
    Jpn J Antibiot; 2000 Jun; 53 Suppl B():22-42. PubMed ID: 12572087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Requirements for intracellular accumulation and release of clarithromycin and azithromycin by human phagocytes.
    Fietta A; Merlini C; Gialdroni Grassi G
    J Chemother; 1997 Feb; 9(1):23-31. PubMed ID: 9106014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The clinical study of azithromycin in otolaryngologic infection].
    Naoya M
    Jpn J Antibiot; 2000 Jun; 53 Suppl B():103-10. PubMed ID: 12572093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phagocyte uptake and transport of azithromycin.
    McDonald PJ; Pruul H
    Eur J Clin Microbiol Infect Dis; 1991 Oct; 10(10):828-33. PubMed ID: 1662626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Azithromycin: mechanisms of action and their relevance for clinical applications.
    Parnham MJ; Erakovic Haber V; Giamarellos-Bourboulis EJ; Perletti G; Verleden GM; Vos R
    Pharmacol Ther; 2014 Aug; 143(2):225-45. PubMed ID: 24631273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacological and pharmacokinetic properties of azithromycin (Zithromac), a novel 15-membered ring macrolide antibacterial agent].
    Matsunaga T
    Nihon Yakurigaku Zasshi; 2001 May; 117(5):343-9. PubMed ID: 11411344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo uptake of azithromycin (CP-62,993) by phagocytic cells: possible mechanism of delivery and release at sites of infection.
    Gladue RP; Bright GM; Isaacson RE; Newborg MF
    Antimicrob Agents Chemother; 1989 Mar; 33(3):277-82. PubMed ID: 2543276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The activity of azithromycin in animal models of infection.
    Pechère JC
    Eur J Clin Microbiol Infect Dis; 1991 Oct; 10(10):821-7. PubMed ID: 1662625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution characteristics of clarithromycin and azithromycin, macrolide antimicrobial agents used for treatment of respiratory infections, in lung epithelial lining fluid and alveolar macrophages.
    Togami K; Chono S; Morimoto K
    Biopharm Drug Dispos; 2011 Oct; 32(7):389-97. PubMed ID: 21812004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrolides and the immune system.
    McDonald PJ; Pruul H
    Scand J Infect Dis Suppl; 1992; 83():34-40. PubMed ID: 1488627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluorescently labeled macrolides as a tool for monitoring cellular and tissue distribution of azithromycin.
    Matijašić M; Munić Kos V; Nujić K; Cužić S; Padovan J; Kragol G; Alihodžić S; Mildner B; Verbanac D; Eraković Haber V
    Pharmacol Res; 2012 Oct; 66(4):332-42. PubMed ID: 22749903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Azithromycin--review of key chemical, pharmacokinetic and microbiological features.
    Lode H; Borner K; Koeppe P; Schaberg T
    J Antimicrob Chemother; 1996 Jun; 37 Suppl C():1-8. PubMed ID: 8818841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and pharmacodynamics of intravenous and oral azithromycin: enhanced tissue activity and minimal drug interactions.
    Rapp RP
    Ann Pharmacother; 1998; 32(7-8):785-93. PubMed ID: 9681095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haemophilus influenzae type b exoproducts induce chemotaxis and macrolide antibiotic release by human polymorphonuclear leukocytes.
    Fontán PA; Buzzola FR; Spinedi EG; Sordelli DO
    Chemotherapy; 1996; 42(1):71-77. PubMed ID: 8751269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and lung distribution of macrolide antibiotics in sepsis model rats.
    Kobuchi S; Fujita A; Kato A; Kobayashi H; Ito Y; Sakaeda T
    Xenobiotica; 2020 May; 50(5):552-558. PubMed ID: 31424300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accumulation and clearance of orally administered erythromycin and its derivative, azithromycin, in juvenile fall chinook salmon Oncorhynchus tshawytscha.
    Fairgrieve WT; Masada CL; McAuley WC; Peterson ME; Myers MS; Strom MS
    Dis Aquat Organ; 2005 Apr; 64(2):99-106. PubMed ID: 15918472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.